Pathological bone resorption in rheumatic diseases |
| |
Authors: | Y Fujikawa N A Athanasou |
| |
Institution: | (1) Nuffield Department of Orthopaedic Surgery and Department of Pathology, University of Oxford, Nuffield Orthopaedic Centre, OX3 7LD Oxford, UK |
| |
Abstract: | Bone resorption in a common feature of rheumatoid and other inflammatory joint conditions. This osteolysis is effected by
osteoclasts, highly specialised multinucleated cells which are formed by fusion of mononuclear phagocyte precursors of haematopoietic
origin. It has been shown that human osteoclast precursors circulate in the monocyte fraction of peripheral blood and are
present in the macrophage population of normal and pathological tissues. The cellular and humoral requirements for human monocyte/macrophage-osteoclast
differentiation are the presence of bone-derived stromal cells, which express the membrane-bound protein termed osteoclast
differentiation factor or osteoprotegerin ligand (ODF/OPGL), and macrophage-colony stimulating factor (M-CSF). Macrophages
form a major component of the inflammatory infiltrate in the rheumatoid synovium and in other conditions such as PVNS and
aseptic loosening. Local factors (e.g. cytokines and growth factors) produced in this microenvironment act to stimulate not
only osteoclast activity but also osteoclast formation. In the context of RA and other joint conditions in which osteolysis
occurs, pathological bone resorption should be regarded as a function not only of osteoclast activity but also of osteoclast
formation from mononuclear phagocyte precursors. |
| |
Keywords: | Rheumatoid arthritis bone resorption osteoclast macrophage |
本文献已被 SpringerLink 等数据库收录! |
|